Fish oil treatment offers hope for babies with liver damage from IV nutrition

This study provides expanded access to Omegaven, a fish oil infusion, for infants and children up to 18 years old who have developed liver disease from long-term IV nutrition. The goal is to lower high liver enzymes and bilirubin levels. Participants must be dependent on IV nutrition and have a direct bilirubin of 2 mg/dL or higher.